Erratum: Association of ABCC2-24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia (PLoS ONE (2014) 9:1 (e82681) DOI:10.1371/journal.pone.0082681);Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Liu, Yan ^a   Yin, You ^b   Sheng, Qi ^a   Lu, Xiaotong ^a   Wang, Fang ^a   Lin, Zhiyan ^a   Tian, Huaiping ^a   Xu, Ajing ^a   Zhang, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2;

ABCC2 GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ANEMIA; ARTICLE; CHILD; CHINESE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; FEVER; FLUORESCENCE POLARIZATION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; KIDNEY INJURY; LEUKOPENIA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ORAL MUCOSITIS; REPEATED DRUG DOSE; RISK ASSESSMENT; THROMBOCYTOPENIA; VOMITING;

ALLELES; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; METHOTREXATE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84896750083     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091384     Document Type: Erratum

References (21)

1. Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166-178. (Pubitemid 43076714)
2. Uga H, Kuramori C, Ohta A, Tsuboi Y, Tanaka H, et al. (2006) A new mechanism of methotrexate action revealed by target screening with affinity beads. Mol Pharmacol 70: 1832-1839.
3. Simon N, Marsot A, Villard E, Choquet S, Khe HX, et al. (2012) Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy. Pharmacogenomics J. doi: 10.1038/tpj.2012.37.
4. de Beaumais TA, Jacqz-Aigrain E (2012) Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children. Curr Drug Metab 13: 822-834.
5. Van Den Bongard HJ, Mathot RA, Beijnen JH, Schellens JH (2000) Pharmacokinetically guided administration of chemotherapeutic agents. Clin Pharmacokinet 39: 345-367.
6. Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, et al. (2009) Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 50: 912-917.
7. Borst P, Oude Elferink RP (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71: 537-592. (Pubitemid 34800230)
8. Huang Y (2007) Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 26: 183-201. (Pubitemid 46452190)
9. Leslie EM, Deeley RG, Cole SP (2005). Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl Pharmacol 204: 216-237. (Pubitemid 40552845)
10. Zhang WX, Chen B, Jin Z, Yu Z, Wang X, et al. (2008) Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients. Xenobiotica 38: 1422-1436.
11. Tanaka T, Uchiumi T, Hinoshita E, Inokuchi A, Toh S (1999) The human multidrug resistance protein 2 gene: Functional characterization of the 59-flanking region and expression in hepatic cells. Hepatology 30: 1507-1512.
12. Rau T, Erney B, Göres R, Eschenhagen T, Beck J, et al. (2006) High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin Pharmacol Ther 80: 468-476. (Pubitemid 44737489)
13. Lopez-Lopez E, Ballesteros J, Piñan MA, Sanchez de Toledo J, Garcia de Andoin N, et al. (2013) Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics 23: 53-61.
14. Ansari M, Sauty G, Labuda M, Gagné V, Laverdière C, et al. (2009) Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. Blood 114: 1383-1386.
15. Hampras SS, Sucheston L, Weiss J, Baer MR, Zirpoli G, et al. (2010) Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia. Int J Mol Epidemiol Genet 1: 201-207.
16. Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, et al. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111: 4477-4489.
17. Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, et al. (2013) A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys 85: e123-e128.
18. Hagleitner MM (2010) Association of a genetic variant in the ABCC2 gene with high methotrexate plasma concentrations in pediatric malignancies. J Clin Oncol 28: 15s.
19. Longo-Sorbello GS, Bertino JR (2001) Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 86: 121-127. (Pubitemid 32216083)
20. Ramsey LB, Panetta JC, Smith C, Yang W, Fan Y, et al. (2013) Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood 121: 898-904.
21. Simple English Wikipedia (2013) Available: http://simple.wikipedia.org/ wiki/Han-Chinese. Accessed 2013 Oct 6.